Your daily source for trading strategies, tech news, and politically incorrect humor.
Hey there, Bullets Fans –
Your Morning Bullets Brief Updates are here!
For access to the latest market stats, the economic data, earnings reports and analyst upgrades and downgrades, just click the menu buttons above.
Otherwise, without any further ado – let’s dig in…
Image Source: Morning Bullets
It’s Monday – and that means the markets are back open.
What are they opening up to?
Well, first of all – stock futures are up, but not by much. News of Trump’s executive orders wasn’t quite as good as a “real” deal from Congress, but at least it is a start.
What else should be on your investing radar this morning?
|
|
Other Top Financial News
ARE YOU TRADING IN THE REAL MARKET?
|
Image Source: WCAI
Something big is on the horizon.
Especially when you think about the fact that the FDA hasn’t considered a new Alzheimer’s treatment for 17 years.
And the one that will have it’s fate decided by March 7, 2021 is the very first therapy that would be approved to actually delay Alzheimer’s progression.
Trials have already demonstrated that the new game-changing drug can work to “untangle” the tell-tale protein clumps that Alzheimer’s leaves behind in the brain.
And while it’s not a cure, it could potentially reverse the ravaging disease.
What’s it called?
|
|
Market Movers & Predictions
|
|
Thanks for reading today and being a loyal subscriber.
Know someone who should be getting these Bullet Briefs?
Make sure to send them over to www.morningbullets.com to subscribe.
Stay tuned for our next edition!
Your biggest fan,
Frederick Frost
P.S. We’d love your opinion.
How useful did you find today’s Morning Bullets?
Not useful – 20.93%
It was ok – 13.90%
It was good – 40.08%